MicroRNA (miRNA) Market - Global Outlook and Forecast 2023-2027

Report ID: 923712 | Published Date: Oct 2024 | No. of Page: 91 | Base Year: 2023 | Rating: 4.7 | Webstory: Check our Web story
1 Introduction to Research & Analysis Reports
    1.1 MicroRNA (miRNA) Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global MicroRNA (miRNA) Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global MicroRNA (miRNA) Overall Market Size
    2.1 Global MicroRNA (miRNA) Market Size: 2021 VS 2027
    2.2 Global MicroRNA (miRNA) Market Size, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top MicroRNA (miRNA) Players in Global Market
    3.2 Top Global MicroRNA (miRNA) Companies Ranked by Revenue
    3.3 Global MicroRNA (miRNA) Revenue by Companies
    3.4 Top 3 and Top 5 MicroRNA (miRNA) Companies in Global Market, by Revenue in 2020
    3.5 Global Companies MicroRNA (miRNA) Product Type
    3.6 Tier 1, Tier 2 and Tier 3 MicroRNA (miRNA) Players in Global Market
        3.6.1 List of Global Tier 1 MicroRNA (miRNA) Companies
        3.6.2 List of Global Tier 2 and Tier 3 MicroRNA (miRNA) Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global MicroRNA (miRNA) Market Size Markets, 2021 & 2027
        4.1.2 Sample collection
        4.1.3 miRNA cDNA Synthesis
        4.1.4 Profiling & Purification
        4.1.5 Detection
        4.1.6 Functional Studies
    4.2 By Type - Global MicroRNA (miRNA) Revenue & Forecasts
        4.2.1 By Type - Global MicroRNA (miRNA) Revenue, 2016-2021
        4.2.2 By Type - Global MicroRNA (miRNA) Revenue, 2022-2027
        4.2.3 By Type - Global MicroRNA (miRNA) Revenue Market Share, 2016-2027
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global MicroRNA (miRNA) Market Size, 2021 & 2027
        5.1.2 Cancer
        5.1.3 Infectious Diseases
        5.1.4 Immunological Disorder
        5.1.5 Cardiovascular Disease
        5.1.6 Neurological Disease
        5.1.7 Others
    5.2 By Application - Global MicroRNA (miRNA) Revenue & Forecasts
        5.2.1 By Application - Global MicroRNA (miRNA) Revenue, 2016-2021
        5.2.2 By Application - Global MicroRNA (miRNA) Revenue, 2022-2027
        5.2.3 By Application - Global MicroRNA (miRNA) Revenue Market Share, 2016-2027
6 Sights by Region
    6.1 By Region - Global MicroRNA (miRNA) Market Size, 2021 & 2027
    6.2 By Region - Global MicroRNA (miRNA) Revenue & Forecasts
        6.2.1 By Region - Global MicroRNA (miRNA) Revenue, 2016-2021
        6.2.2 By Region - Global MicroRNA (miRNA) Revenue, 2022-2027
        6.2.3 By Region - Global MicroRNA (miRNA) Revenue Market Share, 2016-2027
    6.3 North America
        6.3.1 By Country - North America MicroRNA (miRNA) Revenue, 2016-2027
        6.3.2 US MicroRNA (miRNA) Market Size, 2016-2027
        6.3.3 Canada MicroRNA (miRNA) Market Size, 2016-2027
        6.3.4 Mexico MicroRNA (miRNA) Market Size, 2016-2027
    6.4 Europe
        6.4.1 By Country - Europe MicroRNA (miRNA) Revenue, 2016-2027
        6.4.2 Germany MicroRNA (miRNA) Market Size, 2016-2027
        6.4.3 France MicroRNA (miRNA) Market Size, 2016-2027
        6.4.4 U.K. MicroRNA (miRNA) Market Size, 2016-2027
        6.4.5 Italy MicroRNA (miRNA) Market Size, 2016-2027
        6.4.6 Russia MicroRNA (miRNA) Market Size, 2016-2027
        6.4.7 Nordic Countries MicroRNA (miRNA) Market Size, 2016-2027
        6.4.8 Benelux MicroRNA (miRNA) Market Size, 2016-2027
    6.5 Asia
        6.5.1 By Region - Asia MicroRNA (miRNA) Revenue, 2016-2027
        6.5.2 China MicroRNA (miRNA) Market Size, 2016-2027
        6.5.3 Japan MicroRNA (miRNA) Market Size, 2016-2027
        6.5.4 South Korea MicroRNA (miRNA) Market Size, 2016-2027
        6.5.5 Southeast Asia MicroRNA (miRNA) Market Size, 2016-2027
        6.5.6 India MicroRNA (miRNA) Market Size, 2016-2027
    6.6 South America
        6.6.1 By Country - South America MicroRNA (miRNA) Revenue, 2016-2027
        6.6.2 Brazil MicroRNA (miRNA) Market Size, 2016-2027
        6.6.3 Argentina MicroRNA (miRNA) Market Size, 2016-2027
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa MicroRNA (miRNA) Revenue, 2016-2027
        6.7.2 Turkey MicroRNA (miRNA) Market Size, 2016-2027
        6.7.3 Israel MicroRNA (miRNA) Market Size, 2016-2027
        6.7.4 Saudi Arabia MicroRNA (miRNA) Market Size, 2016-2027
        6.7.5 UAE MicroRNA (miRNA) Market Size, 2016-2027
7 Players Profiles
    7.1 Thermofisher Scientific (Life Technologies)
        7.1.1 Thermofisher Scientific (Life Technologies) Corporate Summary
        7.1.2 Thermofisher Scientific (Life Technologies) Business Overview
        7.1.3 Thermofisher Scientific (Life Technologies) MicroRNA (miRNA) Major Product Offerings
        7.1.4 Thermofisher Scientific (Life Technologies) MicroRNA (miRNA) Revenue in Global (2016-2021)
        7.1.5 Thermofisher Scientific (Life Technologies) Key News
    7.2 Agilent Technologies
        7.2.1 Agilent Technologies Corporate Summary
        7.2.2 Agilent Technologies Business Overview
        7.2.3 Agilent Technologies MicroRNA (miRNA) Major Product Offerings
        7.2.4 Agilent Technologies MicroRNA (miRNA) Revenue in Global (2016-2021)
        7.2.5 Agilent Technologies Key News
    7.3 Merck KGaA
        7.3.1 Merck KGaA Corporate Summary
        7.3.2 Merck KGaA Business Overview
        7.3.3 Merck KGaA MicroRNA (miRNA) Major Product Offerings
        7.3.4 Merck KGaA MicroRNA (miRNA) Revenue in Global (2016-2021)
        7.3.5 Merck KGaA Key News
    7.4 QIAGEN (Exiqon)
        7.4.1 QIAGEN (Exiqon) Corporate Summary
        7.4.2 QIAGEN (Exiqon) Business Overview
        7.4.3 QIAGEN (Exiqon) MicroRNA (miRNA) Major Product Offerings
        7.4.4 QIAGEN (Exiqon) MicroRNA (miRNA) Revenue in Global (2016-2021)
        7.4.5 QIAGEN (Exiqon) Key News
    7.5 NanoString Technologies, Inc.
        7.5.1 NanoString Technologies, Inc. Corporate Summary
        7.5.2 NanoString Technologies, Inc. Business Overview
        7.5.3 NanoString Technologies, Inc. MicroRNA (miRNA) Major Product Offerings
        7.5.4 NanoString Technologies, Inc. MicroRNA (miRNA) Revenue in Global (2016-2021)
        7.5.5 NanoString Technologies, Inc. Key News
    7.6 Dharmacon (Horizon Discovery Group)
        7.6.1 Dharmacon (Horizon Discovery Group) Corporate Summary
        7.6.2 Dharmacon (Horizon Discovery Group) Business Overview
        7.6.3 Dharmacon (Horizon Discovery Group) MicroRNA (miRNA) Major Product Offerings
        7.6.4 Dharmacon (Horizon Discovery Group) MicroRNA (miRNA) Revenue in Global (2016-2021)
        7.6.5 Dharmacon (Horizon Discovery Group) Key News
    7.7 Synlogic
        7.7.1 Synlogic Corporate Summary
        7.7.2 Synlogic Business Overview
        7.7.3 Synlogic MicroRNA (miRNA) Major Product Offerings
        7.4.4 Synlogic MicroRNA (miRNA) Revenue in Global (2016-2021)
        7.7.5 Synlogic Key News
    7.8 GeneCopoeia, Inc.
        7.8.1 GeneCopoeia, Inc. Corporate Summary
        7.8.2 GeneCopoeia, Inc. Business Overview
        7.8.3 GeneCopoeia, Inc. MicroRNA (miRNA) Major Product Offerings
        7.8.4 GeneCopoeia, Inc. MicroRNA (miRNA) Revenue in Global (2016-2021)
        7.8.5 GeneCopoeia, Inc. Key News
    7.9 New England Biolabs
        7.9.1 New England Biolabs Corporate Summary
        7.9.2 New England Biolabs Business Overview
        7.9.3 New England Biolabs MicroRNA (miRNA) Major Product Offerings
        7.9.4 New England Biolabs MicroRNA (miRNA) Revenue in Global (2016-2021)
        7.9.5 New England Biolabs Key News
    7.10 Quantabio
        7.10.1 Quantabio Corporate Summary
        7.10.2 Quantabio Business Overview
        7.10.3 Quantabio MicroRNA (miRNA) Major Product Offerings
        7.10.4 Quantabio MicroRNA (miRNA) Revenue in Global (2016-2021)
        7.10.5 Quantabio Key News
    7.11 NanoString Technologies, Inc.
        7.11.1 NanoString Technologies, Inc. Corporate Summary
        7.11.2 NanoString Technologies, Inc. Business Overview
        7.11.3 NanoString Technologies, Inc. MicroRNA (miRNA) Major Product Offerings
        7.11.4 NanoString Technologies, Inc. MicroRNA (miRNA) Revenue in Global (2016-2021)
        7.11.5 NanoString Technologies, Inc. Key News
    7.12 BioGenex
        7.12.1 BioGenex Corporate Summary
        7.12.2 BioGenex Business Overview
        7.12.3 BioGenex MicroRNA (miRNA) Major Product Offerings
        7.12.4 BioGenex MicroRNA (miRNA) Revenue in Global (2016-2021)
        7.12.5 BioGenex Key News
    7.13 SeqMatic LLC
        7.13.1 SeqMatic LLC Corporate Summary
        7.13.2 SeqMatic LLC Business Overview
        7.13.3 SeqMatic LLC MicroRNA (miRNA) Major Product Offerings
        7.13.4 SeqMatic LLC MicroRNA (miRNA) Revenue in Global (2016-2021)
        7.13.5 SeqMatic LLC Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer
100
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
MicroRNA Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
MicroRNA Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
MicroRNA Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports